Karbon-X Project Inc.
CALGARY, AB / ACCESSWIRE / March 28, 2024 / Drax Group, a pioneer in carbon removal and renewable energy, has formed a groundbreaking partnership with environmental leader Karbon-X (OTC PINK:KARX), marking a significant advancement in the deployment of Bioenergy with Carbon Capture and Storage (BECCS) technology in the United States. This collaboration underscores the escalating demand for premium carbon removal solutions.
Under this new agreement, Karbon-X will acquire Carbon Dioxide Removal (CDR) credits from Drax, corresponding to the permanent storage of 25,000 metric tons of carbon dioxide, priced at $350 per metric ton. The contract spans five years, commencing in 2030, and is tied to Drax's forthcoming BECCS initiatives within the United States.
Laurie Fitzmaurice, Drax's President of Carbon Removals, expressed enthusiasm about partnering with entities like Karbon-X that recognize the critical need for immediate investment in superior carbon removals. With the CDR market quickly evolving, there's an anticipated shortage of supply as entities worldwide near their carbon reduction milestones. "We're excited to work with organizations like Karbon-X that understand the importance of investing in high-quality carbon removals today. The CDR market, which is already maturing at a rapid pace, is expected to experience a supply crunch within the next decade as companies and countries approach their deadlines for carbon reduction targets." said Laurie Fitzmaurice, President, Carbon Removals at Drax.
This partnership is a continuation of Drax's commitment to leading in carbon removal efforts, following agreements with other significant players and the establishment of a dedicated business unit aimed at spearheading global carbon removals, targeting the extraction of at least 6 million tons of CO2 annually from the atmosphere.
BECCS technology, celebrated for its ability to produce renewable energy from sustainable biomass while capturing and permanently storing CO2, is becoming increasingly sought after for its verifiable impact, especially when compared to nature-based removal methods.
Fitzmaurice highlighted the significance of this deal with Karbon-X in propelling the implementation of BECCS in the U.S., catering to the soaring demand for decarbonization solutions. Karbon-X plans to resell the purchased credits in the voluntary carbon market, aiding companies, and individuals in achieving their emission reduction goals by choosing high-caliber projects like Drax's BECCS.
Chad Clovis, CEO of Karbon-X, praised the partnership with Drax as a monumental stride towards addressing climate change and fostering a sustainable future. "We are thrilled to be working alongside Drax in their pursuit of their carbon removals program. This partnership represents significant progress in our collective mission to combat climate change and build a more sustainable future." said Chad Clovis, CEO of Karbon-X.
As the global community increasingly turns to engineered carbon removal solutions to fulfill climate pledges, the distinct, quantifiable benefits of BECCS have positioned it as a cornerstone of high-integrity CDR efforts.
For more insights into Drax's role in supporting organizational sustainability ambitions through premier carbon removal services, please visit their website.
About Drax
Drax Group is committed to fostering a zero-carbon, cost-effective energy future. Announced in 2019, Drax's ambition to become carbon negative by 2030 leverages BECCS technology. The company's diverse team of 3,000 employees focuses on electricity generation, business electricity sales, and the production and supply of compressed wood pellets. Learn more at Drax's website, www.drax.com.
About Karbon-X
Karbon-X stands at the forefront of environmental action, offering a user-friendly platform for individuals to engage in meaningful carbon offset projects. Committed to transparency and convenience, Karbon-X supports initiatives that significantly reduce greenhouse gas emissions, empowering users to contribute to global climate change mitigation. Specializing in delivering offsets to consumers and businesses, Karbon-X is working to democratize access to carbon offsets globally. For more information, see www.karbon-x.com
Contact for Media Inquiries:
Drax Group
Alex Schott
VP, North America Communications
Email: alex.schott@drax.com
Phone: 318 - 372 - 4091
Karbon-X
Daniel Haigh
Head of Marketing
Email: dh@karbon-x.com
Phone: 587 - 577 - 3863
SOURCE: Karbon-X Project Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
